GI-5005

N/A

Report date: 2022/11/25 17:31:36

Base Information

Drug NameGI-5005

Drug Alias NameTarmogenGI-5005

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulantsT lymphocytes stimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis C, ChronicHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGlobeimmune Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesGlobeimmune Inc

Active IndicationsN/A

Inactive IndicationsHepatitis C, ChronicHepatitis C

ATC CodeN/A